$0.07357
-1.51%$0.07357
-1.51%Vote to see the social sentiment of BEAT now
*The projected profit is calculated based on the average token price of this year. Please be noted this is not financial advice.

With the volatility of the cryptocurrency market, everyone is curious about the direction and price of BEAT, both in short term and long term.
BEAT can go as high as $0.1251 from now until 2030.
The potential ROI of buying BEAT at current price of $0.07357 is +70.00% , The all-time-high of BEAT is $11.53 .
BEAT has moved -1.51% in the last 24 hours, and -14.28% in the past 7 days. For more information, see BEAT price now.
For 2026, BEAT is estimated to achieve an average price of $0.07299, with an expected of high $0.08685 and a potential low of $0.06277. Buying BEAT at the current price of $0.07357 can potentially yield 0 in 2026.
Past trends and patterns indicate that BEAT may make a high of $0.1126, with the lowest price of $0.05674 in 2027. So buying BEAT at the current price of $0.07357, the potential ROI based on average price of $0.07992 in 2027 will be +8.00%.
BEAT is forecasted to hover around $0.0963 for most parts in 2028, with an expected low of $0.05008 and expected high of $0.1232. Based on this forecast, you can expect a potential ROI of +30.00% if you buy at current market price of $0.07357.
Based on historical data, BEAT may make a high of $0.1405, with $0.06477 as the lowest price in 2029. So if you were to buy BEAT at the current price of $0.07357, the potential ROI for you in 2029 is +49.00% as it makes its way to the average price of $0.1097.
In 2030, the lowest price to be seen from BEAT is estimated at $0.07009, while the peak price of the year may well be around $0.1614. With an average price of $0.1251, your potential ROI in 2030 if you buy at market price of $0.07357 is +70.00%.
Following the market sentiment in previous years, BEAT is predicted to make movements between $0.08741 and $0.1662, with the average price of $0.1433 in 2031. Buying BEAT at current price of $0.07357 should bring you the potential ROI of +94.00% if you HODL it until 2031.
| Year | Minimum Price | Highest Price | Average Price | Change |
|---|---|---|---|---|
| 2026 | $0.06277 | $0.08685 | $0.07299 | -- |
| 2027 | $0.05674 | $0.1126 | $0.07992 | +8.00% |
| 2028 | $0.05008 | $0.1232 | $0.0963 | +30.00% |
| 2029 | $0.06477 | $0.1405 | $0.1097 | +49.00% |
| 2030 | $0.07009 | $0.1614 | $0.1251 | +70.00% |
| 2031 | $0.08741 | $0.1662 | $0.1433 | +94.00% |
BEAT | 13.57 BEAT |
|---|---|
$0.9499USD | |
€0.9499EUR | |
₹95.12INR | |
Rp18,058.82IDR | |
$1.35CAD | |
£0.8142GBP | |
฿33.38THB |
BEAT | 13.57 BEAT |
|---|---|
₽83.04RUB | |
R$5.02BRL | |
د.إ3.66AED | |
₺49.53TRY | |
¥6.64CNY | |
¥157.81JPY | |
$7.87HKD |

US September CPI came in at 3.7% year-over-year, beating expectations. Bitcoin briefly fell below $80,300, and liquidations over 24 hours topped $900 million. A deep-dive review with a liquidation heatmap, options positioning distribution, and a scenario analysis of the Fed’s rate-hike path.

Morgan Stanley’s third-quarter earnings and revenue beat expectations. Stock trading revenue jumped 41%, yet MS shares still fell nearly 3%. Weak fixed income performance, still-hot inflation, and rate pressures weighed on valuations.

Johnson & Johnson’s third-quarter earnings beat expectations and the company raised its guidance, yet the stock fell more than 5%. In this article, we break down the core logic behind why the company’s pharmaceutical growth failed to offset weakness in its MedTech business across three dimensions: MedTech revenue coming in below expectations, a valuation re-rating, and the sepa
BEAT(BEAT) has a future price prediction of $0.1433. It is expected that by 2027, BEAT(BEAT) may reach a new high of $11.53. Considering its market cap ranking of 702, BEAT(BEAT) is expected to continue its strong growth momentum.